This opportunity is no longer accepting applications.
grant PAR-23-119
Catalytic Tool and Technology Development in Kidney, Urologic, and Hematologic Diseases (R21 Clinical Trial Not Allowed)
This grant is designed to support the creation of new and innovative tools and technologies that aid in the study and treatment of kidney, urologic, and blood-related diseases.
The purpose of this Funding Opportunity Announcement is to promote development of innovative, enabling tools and technologies in the areas of kidney, urologic, and hematologic diseases.
Funding Source
Agency: National Institutes of Health
Sub-agency: National Institute of Diabetes and Digestive and Kidney Diseases
Program: SBIR
Awards & funding
Award Ceiling: $275,000
Award Amount: $275,000
Dates
Opportunity Released: April 11, 2023
Open for Submission: April 11, 2023
Submission Deadline: January 7, 2025
Application Window Closes: January 7, 2025
Supporting links
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers